Page 15 - Bd Becton News Today

Share this article Share this article FRANKLIN LAKES, N.J., April 20, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep ™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) to the user level due to a defective applicator. The product is used as an antiseptic for the preparation of the patients skin prior to surgery to help r...

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular...

BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021 News provided by Share this article Share this article FRANKLIN LAKES, N.J., April 5, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the second quarter of fiscal year 2021 on Thursday, May 6, 2021. BD will issue a press release detailing the quarters results, along with related presentation materials posted to www.bd.com/investors, at approxim...

Share this article Share this article FRANKLIN LAKES, N.J., April 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its rapid antigen test to be used for SARS-CoV-2 screening through serial testing of asymptomatic individuals. BD today announced the FDA has granted Emergency Use Authorization (EUA) for its BD Veritor�...

Share this article Share this article TUCSON, Ariz., April 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the companys supply chain, serving as a final-stage manufacturing and sterilization center.   The new 120,000 square-foot facility will be built on approximately 32 acres at the northeast corner ...

BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting Reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor™ Plus System News provided by Share this article Share this article FRANKLIN LAKES, N.J., March 9, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection ...

Share this article FRANKLIN LAKES, N.J., March 4, 2021 /PRNewswire/ --  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, Inc. ("GSL"), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further i...

Share this article Share this article FRANKLIN LAKES, N.J., Feb. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Scanwell Health, a leader in smartphone-enabled at-home medical tests, today announced a collaboration to create an at-home rapid test for SARS-CoV-2 using a BD antigen test and the Scanwell Health mobile app. As part of the collaboration, BD plans to produce a lateral flow antigen test and pair it with the Sc...